How does a safety database simplify pharmacovigilance?

Across clinical development and post-marketing, organizations collect, assess, and report safety information as part of pharmacovigilance to protect patients and meet regulatory requirements. Sponsors and marketing authorization holders need to keep track of adverse events reported in relation to the medicines they study or commercialize, then submit relevant cases to the appropriate authorities. A safety database supports this pharmacovigilance work by centralizing adverse event intake, case processing, medical coding, and electronic reporting, so safety teams can work consistently and demonstrate compliance.

Why is safety reporting required?

Safety reporting exists so sponsors, partners, and regulators can monitor whether a medicine continues to have an acceptable benefit-risk profile. In practice, adverse events are collected, reviewed, and assessed to determine whether they need to be reported to health authorities, ethics committees, partners, or other stakeholders. Regulators use this information to monitor emerging risks, request clarification when needed, and decide whether further action is required, such as label changes, additional risk controls, or further investigation. Modern pharmacovigilance processes are defined through International Council for Harmonisation (ICH) guidance and regional regulations, which set out what must be reported, when, and to whom.

What is a safety database?

A safety database is specialized software for collecting and managing individual case safety reports, often called ICSRs. These systems support a full workflow from case intake through assessment and regulatory submission. At the core is the ICH E2B(R3) ICSR standard, which defines the data elements and message structure used to exchange ICSRs with regulators.

How is a safety database used?

Typical uses include:

• Intake and case creation: capture events from trials, spontaneous sources, literature, partners, and patient programs

• Triage and case processing: assess seriousness and expectedness, manage follow up, and assemble the full ICSR

• Medical coding:  code events in MedDRA, the standard medical terminology used to classify adverse events, and products in WHODrug, the global medicinal product dictionary, for consistency and analysis 

• Narratives and attachments: author clinical narratives and manage supporting documents

• Duplicate detection: screen new cases against the database to prevent duplicate reporting

• Electronic reporting: generate and transmit E2B(R3) messages to regional authorities and partners that must be informed about adverse events in markets where the product is registered, then track acknowledgments and manage authority queries in the system

• Signal screening: perform basic analytics to explore potential safety signals

• Compliance logging: maintain audit trails, version history, and e-signatures to support inspections

Regulatory standards at a glance

Regulators worldwide have adopted ICH E2B(R3) for electronic ICSR exchange. The ICH implementation guide defines the structure, data elements, and acknowledgments. Regional authorities, including the EMA, FDA, PMDA, and NMPA, publish technical guides with local elements and rules. In addition, most safety databases support MedDRA for event coding and WHODrug for medicinal product coding, with clear version control to maintain consistency across regions.

Core features to expect  in  safety database

• Configurable intake for clinical, spontaneous, literature, and partner sources with validation at entry

• E2B(R3) authoring and validation that flags missing or inconsistent elements against ICH and regional rules

• Medical coding tools for MedDRA and WHODrug, with dictionary version control

• Electronic transmission and acknowledgments to regional gateways, with tracking of interchange status and acknowledgment (ACK) outcomes

• Duplicate checking across sources to prevent over-reporting

• Audit trails and e-signatures for compliance with regulatory requirements

• Data import and export in XML and tabular formats for reconciliation and partner exchange

• Integration with EDC, CTMS, and data warehouses to improve timeliness and reduce re-entry

Key benefits of using a safety database

1. Consistency and data quality

Validation at entry and structured workflows help ensure complete, consistent ICSRs, which reduces follow up and rework.

2. Regulatory compliance

Alignment with ICH E2B(R3) and regional guides support reliable submissions and inspection readiness.

3. Timeliness and throughput

Electronic intake, coding, and transmission shorten cycle times from initial report to regulatory submission, improving case throughput.

4. Transparency across stakeholders

Role-based access and traceability make it clear who performed each action and when, which improves collaboration with partners and affiliates.

5. Proactive safety insight

Consolidated data and basic signal views help teams spot patterns early and prioritize follow up for patient protection.

Selecting a safety database

When evaluating options, consider:

• E2B(R3) coverage and regional alignment for the markets in scope, including FDA, EMA, CDE, MFDS, and PMDA requirements

• Medical dictionaries and versioning with robust MedDRA and WHODrug support and clear upgrade processes

• Workflow configurability for triage rules, follow up tasks, approvals, and partner routing

• Transmission and acknowledgment tracking with automated submission, retransmission handling, and readable error details

• Duplicate detection and reconciliation across clinical and post-marketing sources

• Security and compliance with role-based access, e-signatures, complete audit trails, and validation documentation

• Integration capabilities to map and synchronize with EDC and other eClinical systems

• Scalability and support for portfolio scale, global access, training, and vendor assistance during live operations

Simplify pharmacovigilance with cubeSAFETY

cubeSAFETY is a validated safety database designed to support complete, compliant ICSR management from intake to regulatory submission. It helps safety teams work consistently across regions while maintaining traceability and control.

• Case intake and processing

  Configurable intake for clinical, spontaneous, partner, and literature sources with validation at entry. Structured triage for seriousness and expectedness, follow up tasking, and configurable workflows for medical and safety review.  When used in the context of a clinical trial, cubeSAFETY is fully integrated with cubeCDMS, CRScube’s Electronic Data Capture (EDC) system, helping pre-populate case forms with data already entered during adverse event reporting.

• E2B(R3) authoring and validation

  Guided ICSR authoring with checks against ICH E2B(R3) and regional rules. Validation is performed at the point of entry, rather than through batch post-processing, so missing or inconsistent elements can be addressed earlier to improve data quality and support more reliable submissions.

• Medical coding and dictionaries

  Event coding in MedDRA and product coding in WHODrug with version control, dictionary upgrades, reconciliation tools, and AI-assisted coding to help improve coding consistency and data quality across studies and markets.

• Electronic transmission and acknowledgments

  Direct Gateway submissions with the top 5 regulatory agencies (FDA, EMA, CDE, MFDS, and PMDA) with full tracking of interchange status, acknowledgments, errors, nullifications, and amendments. Resubmission support with audit history.

• Duplicate detection and reconciliation

  Matching logic to detect potential duplicates across sources and partners, plus tools to reconcile partner case exchange.

• Audit, security, and compliance

  Role based access, e-signatures, and complete audit trails for all actions. Validation documentation available to support inspections and change control.

• Oversight and reporting

  Dashboards and operational reports for workload, cycle times, case status, overdue follow ups, and submission timeliness. Exports for metrics and quality reviews.

• Integration and scale

  APIs and data exchange for EDC, CTMS, and data warehouses. Support for multi study, multi region portfolios with configurable workflows and templates.

Exploring safety database options? Contact us for a tailored demo.